Upadhyaya Meena, Cooper David N
Institute of Medical Genetics, University of Wales College of Medicine, Heath Park, Cardiff CF14 4XN, UK.
Expert Rev Mol Diagn. 2002 Mar;2(2):160-71. doi: 10.1586/14737159.2.2.160.
Facioscapulohumeral muscular dystrophy (FSHD) is the third most common inherited neuromuscular disorder after Duchenne muscular dystrophy and myotonic dystrophy. The gene underlying FSHD was mapped to chromosome 4q35 in 1990 and was shown to be closely linked to locus D4F104S1. Although D4F104S1-associated deletions are closely associated with FSHD, the identity and location of the FSHD gene (or genes) still remain elusive, as does the mechanistic basis of the disease. In addition, although approximately 5% of FSHD families fail to exhibit linkage to 4q35, a putative second locus remains unidentified. The search for the FSHD gene has been hampered both by sequence homologies between the 4q35 candidate region and other chromosomal regions and by the presence of many highly repetitive sequences. Molecular diagnosis for FSHD is usually offered with 98% accuracy but because of its complexity, a much more simple test would be preferable. Indeed, the identification of the FSHD gene itself should potentiate major improvements in diagnostic testing.
面肩肱型肌营养不良症(FSHD)是继杜氏肌营养不良症和强直性肌营养不良症之后的第三大常见遗传性神经肌肉疾病。1990年,FSHD相关基因被定位到4号染色体长臂3区5带(4q35),并显示与D4F104S1基因座紧密连锁。尽管与D4F104S1相关的缺失与FSHD密切相关,但FSHD基因(或多个基因)的身份和位置仍然难以确定,疾病的发病机制也是如此。此外,尽管约5%的FSHD家系未显示与4q35连锁,但假定的第二个基因座仍未确定。对FSHD基因的寻找受到了4q35候选区域与其他染色体区域之间的序列同源性以及许多高度重复序列的阻碍。FSHD的分子诊断通常准确率为98%,但由于其复杂性,更简单的检测方法会更可取。事实上,FSHD基因本身的鉴定应该会使诊断检测有重大改进。